Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NR3C2 Gene Hypertension early onset NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
NR3C2 Gene Pseudohypoaldosteronism, type 1, autosomal dominant NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Comprehensive Nephrology Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 299 |
|
Renal Stone/Electrolyte Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 82 | 71 |
|
Invitae Expanded Renal Disease Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 693 | 388 |
|
NR3C2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Renal Tubular Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 68 | 39 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 525 | 338 |
|
Pseudohypoaldosteronism Type I Panel PreventionGenetics, part of Exact Sciences United States | 2 | 4 |
|
Autosomal Dominant Pseudohypoaldosteronism Type 1 via the NR3C2 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Genomic Unity® Renal Disorders Analysis Variantyx, Inc. United States | 1 | 425 |
|
Hypertension (WES based NGS panel of 15 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 15 |
|
Pseudohypoaldosteronism (WES based NGS panel of 9 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 9 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.